Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
52.39M
Enterprise Value
84.57M
Income
-97.57M
Sales
2.80M
Book/sh
6.16
Cash/sh
2.55
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
192
IPO
Feb 02, 2022
P/E
-
Forward P/E
-
PEG
-
P/S
18.71
P/B
0.34
P/C
0.82
P/FCF
-
EV/EBITDA
-
EV/Sales
30.21
Quick Ratio
0.97
Current Ratio
0.97
Debt/Eq
0.63
LT Debt/Eq
0.23
Option/Short
Yes / Yes
EPS (ttm)
-5.31
EPS next Y
-
EPS next Q
-
EPS this Y
95.18%
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
-19.70% -29.91%
Sales past 3/5Y
14.49% 7.60%
EPS Y/Y TTM
-7.51%
Sales Y/Y TTM
-52.63%
EPS Q/Q
10.46%
Sales Q/Q
-100.00%
Insider Own
-
Insider Trans
-
Inst Own
1.36%
Inst Trans
-59.80%
ROA
-38.24%
ROE
-65.99%
ROIC
-51.70%
Gross Margin
-434.25%
Oper. Margin
-1740.00%
Profit Margin
-3478.95%
SMA20
-11.50%
SMA50
-28.81%
SMA200
-66.10%
Trades
Shs Outstand
24.79M
Shs Float
-
52W High
20.70 -89.86%
52W Low
1.99 5.53%
Volatility
3.36% 5.37%
ATR (14)
0.15
RSI (14)
30.54
Beta
2.56
Rel Volume
0.44
Avg Volume
26.92K
Volume
7,293
Perf Week
-2.33%
Perf Month
-20.45%
Perf Quarter
-47.92%
Perf Half Y
-70.98%
Perf YTD
-79.21%
Perf Year
-89.01%
Perf 3Y
-89.76%
Perf 5Y
-
Perf 10Y
-
Prev Close
2.01
Price
2.10
Change %
4.62%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Chardan Capital Markets Buy $4
NOVONIX Ltd. engages in the revolutionizing the global lithium-ion battery industry with innovative, sustainable technologies, high-performance materials, and more efficient production methods. The firm manufactures industry battery cell testing equipment, is growing its high-performance synthetic graphite material manufacturing operations, and has developed a patented all-dry, zero-waste cathode synthesis process. The firm operates through the following segments: Battery Materials, Battery Technology, and Graphite Exploration. NOVONIX was founded by Gregory Alexander John Baynton in April 2012 and is headquartered in Brisbane, Australia.
CEOMr. Michael O'Kronley
CPAMr. Ronald Cleve Edmonds B.B.A.
Chief Legal & Risk OfficerMs. Kimberly Heimart
C.A.Ms. Suzanne Margaret Yeates B.Bus